España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Innate Pharma
IPHA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.79
0.03
1.70%
At close: -
$1.74
-0.05
-2.79%
After Hours: 9:28 AM EDT
Get Report
Comment
Innate Pharma (IPHA) Forecast
News
Earnings
Innate Pharma (IPHA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Innate Pharma (NASDAQ:IPHA) Stock
Innate Pharma Stock (NASDAQ: IPHA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 27, 2025
Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Innate Pharma Doses First Patient In Phase 1 ...
Benzinga Newsdesk
Tuesday, January 21, 2025
Innate Pharma To Host Investor And Analyst Ev...
Benzinga Newsdesk
Friday, January 17, 2025
HC Wainwright & Co. Reiterates Buy on Innate ...
Benzinga Newsdesk
Friday, January 10, 2025
Innate Pharma Unveils Transformative Strategy...
Benzinga Newsdesk
Monday, December 16, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, December 09, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Innate Pharma shares are trading higher after...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Innate ...
Benzinga Newsdesk
Innate Pharma's TELLOMAK Phase 2 Trial: Lacut...
Benzinga Newsdesk
Friday, December 06, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Innate Pharma And The Institute For Follicula...
Benzinga Newsdesk
Tuesday, December 03, 2024
Innate Pharma To Showcase Lacutamab And SAR44...
Benzinga Newsdesk
Tuesday, November 19, 2024
Innate Pharma Publishes Preclinical Data Demo...
Benzinga Newsdesk
Friday, November 15, 2024
HC Wainwright & Co. Reiterates Buy on Innate ...
Benzinga Newsdesk
Wednesday, November 13, 2024
Innate Pharma's Revenue For The Nine Months €...
Benzinga Newsdesk
Tuesday, November 12, 2024
HC Wainwright & Co. Reiterates Buy on Innate ...
Benzinga Newsdesk
Friday, November 08, 2024
Innate Pharma's Oncology Pipeline At SITC 202...
Benzinga Newsdesk
Monday, October 14, 2024
Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday
Avi Kapoor
Innate Pharma Names Jonathan Dickinson As New...
Benzinga Newsdesk
Monday, September 30, 2024
Innate Pharma to Co-Host Next-Gen Immunothera...
Benzinga Newsdesk
Monday, September 23, 2024
Innate Pharma Announced That The US FDA Has C...
Benzinga Newsdesk
Friday, September 13, 2024
HC Wainwright & Co. Reiterates Buy on Innate ...
Benzinga Newsdesk
Thursday, September 12, 2024
Innate Pharma H1 EPS €(0.31) Down From €0.02 ...
Benzinga Newsdesk
Monday, September 09, 2024
Innate Pharma And AstraZeneca Reveal Monalizu...
Benzinga Newsdesk
Monday, June 17, 2024
Innate Pharma And Sanofi's Blood Cancer Treat...
Benzinga Newsdesk
Wednesday, June 12, 2024
HC Wainwright & Co. Reiterates Buy on Innate ...
Benzinga Newsdesk
Tuesday, June 04, 2024
Innate Pharma Reveals Results From TELLOMAK P...
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Innate ...
Benzinga Newsdesk
Innate Pharma's Four Abstracts With Innate's ...
Benzinga Newsdesk
Tuesday, May 14, 2024
Innate Pharma Reported Q1 Revenue Of €6.6M Do...
Benzinga Newsdesk
Monday, April 15, 2024
Innate Pharma Advances Sanofi-Developed NK Ce...
Benzinga Newsdesk
Thursday, April 11, 2024
HC Wainwright & Co. Reiterates Buy on Innate ...
Benzinga Newsdesk
Wednesday, April 10, 2024
Innate Pharma Presents Preclinical Efficacy O...
Benzinga Newsdesk
Friday, April 05, 2024
Innate Pharma Says It Filed Its 2023 Universa...
Benzinga Newsdesk
Wednesday, April 03, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, April 01, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, March 22, 2024
HC Wainwright & Co. Reiterates Buy on Innate ...
Benzinga Newsdesk
Thursday, March 21, 2024
Earnings Scheduled For March 21, 2024
Benzinga Insights
Innate Pharma FY EPS $(0.10) Up From $(0.75) ...
Benzinga Newsdesk
Monday, March 11, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Wednesday, March 06, 2024
Innate Pharma Announces That It Will Present ...
Benzinga Newsdesk
Innate Pharma's First Patient Dosed In Phase ...
Benzinga Newsdesk
Tuesday, February 06, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Thursday, January 04, 2024
Innate Pharma Announces FDA's Removal Of Part...
Benzinga Newsdesk
Wednesday, December 20, 2023
Innate Pharma Filed For Stock Shelf Of Up To $200M-
Charles Gross
Tuesday, December 19, 2023
Sanofi To Exercise Option To License A New AN...
Benzinga Newsdesk
Monday, December 18, 2023
Innate Pharma CEO Mondher Mahjoubi To Depart ...
Benzinga Newsdesk
Monday, December 11, 2023
Reported On Sunday, Innate Pharma To Present ...
Benzinga Newsdesk
Show More
